MPM BioVentures 2014, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), bought 203,687 shares at $19.00 ($3.0M) on 2020-07-28, disclosed to the SEC on 2020-07-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 43,687 | $0 | 0.0% |
| 2 | $19.00 | 1,121 | $21K | 0.7% |
| 3 | $19.00 | 3,020 | $57K | 1.9% |
| 4 | $19.00 | 3,096 | $59K | 1.9% |
| 5 | $19.00 | 5,994 | $114K | 3.7% |
| 6 | $19.00 | 56,814 |
| $1.1M |
| 35.5% |
| 7 | $19.00 | 89,955 | $1.7M | 56.2% |
| Total | $14.92 avg | 203,687 | $3.0M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |